INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and ...

Wolfe Research downgraded shares of Innovative Industrial Properties (NYSE:IIPR – Free Report) from an outperform rating to a ...

Allspring Global Investments Holdings LLC trimmed its holdings in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 1.2% in the first quarter, HoldingsChannel reports. The institutional investor owned ...

Highland Capital Management LLC increased its stake in Wells Fargo by 56.8% in the first quarter, adding 10,003 shares. The ...

By Travis Fischer, [email protected] The Charles City Community School Board plans to pursue a $30 million bond ...

Gavin Newsom enacted two laws Monday to exempt urban housing development from excessive environmental review.The change could ...

Investing.com -- Inovio Pharmaceuticals Inc (NASDAQ: INO) stock plunged 14% after the company announced plans for an underwritten public offering of its common stock and warrants.

Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the closing of its ...

Citigroup received a bullish boost as Goldman Sachs increased its target price from $85 to $96, labeling it a “buy.” This ...

Shares of SoundHound AI are trading higher Wednesday afternoon. In recent weeks, financial analysts have shown confidence in ...

Michael Kantrowitz, Piper Sandler chief investment strategist, joins 'The Exchange' to discuss how to play the weak dollar, his read on recent economic data and markets.

UnitedHealth stock price has imploded in the past few months, making it one of the worst-performing companies in the S&P 500 Index ...